课题基金 / 基金详情

Structure-Function of Drug Metabolizing Enzymes

Structure-Function of Drug Metabolizing Enzymes
药物代谢酶的结构-功能
批准号:
6432314
负责人:
JOYCE GOLDSTEIN
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

JOYCE GOLDSTEIN的其他基金

相似基金

相关文献

中文摘要
翻译
目的:确定CYP酶在人体内具有药物特异性和异种特异性的原因。CYP2C亚家族在基因水平上是高度同源的,但在底物特异性上有显著差异。CYP2C9特异性代谢一些抗炎药物,如布洛芬和双氯芬酸。相反,密切相关的CYP2C19特异性代谢其他药物,如抗惊厥药甲苯妥英。本研究的目的是确定参与底物特异性的氨基酸,并解决这些CYP2Cs的结构。结构活性研究将有助于预测哪些药物将被这些多态酶代谢。我们使用甲苯妥英作为人CYP2C19的原型底物。CYP2C9与CYP2C19嵌合体的初步实验表明,CYP2C19需要多个底物识别位点才能识别和代谢特定的底物。初步实验表明,Gotoh提出的底物识别位点(SRS) (SRS1)中的I99H与FG环中的220Ser Pro和220Pro Thr以及2C19的SRS 3和14结合,才能将CYP2C9转化为高周转率的甲苯托英羟化酶。后来的定点诱变实验表明,需要I99H、S221P、P221T和SRS中的三个氨基酸才能将CYP2C9转化为甲苯托英羟化酶。这是286 2292 295。因此,CYP2C19特异性似乎需要多个区域,尽管相反,将CYP2C19转化为类似2C9的酶只需要很少的改变。农药和环境化学物质的底物特异性表明,某些有机磷农药,如毒死蜱,至少部分是由CYP2C19代谢的。
英文摘要
AIMS: To determine the reason for drug and xenobiotic specificity of the CYP enzymes in humans. The CYP2C subfamily is highly homologous at the gene level, but differ markedly in their substrate specificity. CYP2C9 specifically metabolizes a number of anti-inflammatory drugs such as ibuprofen and diclofenac. In contrast, the closely related CYP2C19 specifically metabolizes other drugs such as the anticonvulsant mephenytoin. The aims of this study are to define the amino acids involved in substrate specificity and solve the structure of these CYP2Cs. Structure activity studies will help predict which drugs will be metabolized by these polymorphic enzymes. ACCOMPLISHMENTS: We used mephenytoin as a prototype substrate for human CYP2C19. Preliminary experiments with chimeras between CYP2C9 and CYP2C19 indicated that multiple substrate recognition sites are necessary for CYP2C19 to be able to recognize and metabolize specific substrates Preliminary experiments suggest that I99H in a substrate recognition site (SRS) (SRS1) proposed by Gotoh in combination with 220Ser Pro and 220Pro Thr in the FG loop and SRS 3 and 14 of 2C19 are required to convert CYP2C9 to a high turnover mephenytoin hydroxylase. Later site directed mutagenesis experiments indicate that I99H, S221P, P221T, and three amino acids in SRS are required to convert CYP2C9 to a mephenytoin hydroxylase. These are 286, 2292, and 295. Therefore multiple regions appear to be required for CYP2C19 specificity, although conversely, only a few changes are required for to convert CYP2C19 to a 2C9 like enzyme. Substrate specificity with pesticides and environmental chemicals indicate that certain organophosphorus pesticides such as chlorpyrofos are metabolized at least in part by CYP2C19.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DRUG METABOLIZING ENZYMES IN HUMANS AND ANIMAL MODELS
IDENTIFICATION OF MOUSE CYP2C INVOLVED IN ARACHIDONIC ACID
Mouse Cyp2c Involved In Arachidonic Acid
Identification Of Mouse Cyp2c Involved In Arachidonic Ac
海外基金